Literature DB >> 8188532

Enhancement of blood stasis and vascular permeability in Meth-A tumors by administration of hyperthermia in combination with tumor necrosis factor.

H Umeno1, N Watanabe, N Yamauchi, N Tsuji, T Okamoto, Y Niitsu.   

Abstract

Blood stasis and vascular permeability induced by tumor necrosis factor (TNF) in Meth-A tumors transplanted in BALB/c mice were significantly enhanced by hyperthermia at 40 degrees C for 30 min immediately following TNF administration. A dose-dependent, sustained decline in the intratumoral blood flow rate occurred following the administration of TNF alone (i.v.; 5 x 10(3), 5 x 10(4), or 5 x 10(5) JRU/kg) and was enhanced by the administration of hyperthermia in combination with the TNF, even though no decline occurred with hyperthermia alone. The combination of TNF at 5 x 10(5) JRU/kg and hyperthermia resulted in a blood flow ratio (ratio of blood flow after administration to that before) of 0.47 at 1 h compared with a ratio of 0.65 at 1 h after TNF alone. The blood flow in normal skin sites did not decrease in any case. The permeability of the intratumoral vasculature similarly increased in a dose-dependent manner after the administration of TNF alone and was further increased by combination with hyperthermia, even though no increase occurred with hyperthermia alone. The mean permeability in mice receiving TNF alone at 5 x 10(5) JRU/kg was 1.35 times that in untreated mice. In mice receiving TNF at the same dose together with hyperthermia, the ratio was increased to 1.65. The results suggest that TNF selectively suppresses intratumoral blood flow, that this effect is enhanced by mild hyperthermia, and that the mechanism of the suppression by TNF with or without hyperthermia partly involves an increase in blood vessel permeability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188532      PMCID: PMC5919447          DOI: 10.1111/j.1349-7006.1994.tb02100.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


tumor necrosis factor methylcholanthrene‐induced A‐cells intradermal(ly) intraperitoneal(ly) intravenous(ly) specific pathogen‐free Japan reference unit
  33 in total

1.  Successful treatment of a case of hepatocellular carcinoma with tumor necrosis factor and local hyperthermia.

Authors:  M Maeda; N Watanabe; N Yamauchi; Y Tsuji; Y Niitsu
Journal:  Gastroenterol Jpn       Date:  1991-12

2.  Therapeutic and toxic activity of tumor necrosis factor is synergistic with gamma interferon.

Authors:  J E Talmadge; O Bowersox; H Tribble; M Shepard; D Liggitt
Journal:  Pathol Immunopathol Res       Date:  1989

3.  Toxic effect of tumor necrosis factor on tumor vasculature in mice.

Authors:  N Watanabe; Y Niitsu; H Umeno; H Kuriyama; H Neda; N Yamauchi; M Maeda; I Urushizaki
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

4.  Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum.

Authors:  F C Kull; P Cuatrecasas
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

5.  Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor.

Authors:  T Okamoto; N Watanabe; N Yamauchi; Y Tsuji; N Tsuji; Y Itoh; H Neda; Y Niitsu
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

6.  Alterations in tumor microvasculature during hyperthermia.

Authors:  H A Eddy
Journal:  Radiology       Date:  1980-11       Impact factor: 11.105

7.  Effects of murine tumor necrosis factor on heterotransplanted human tumors.

Authors:  L Helson; C Helson; S Green
Journal:  Exp Cell Biol       Date:  1979

8.  Rabbit tumor necrosis factor: mechanism of action.

Authors:  M R Ruff; G E Gifford
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

9.  A combined therapy of hyperthermia and tumor necrosis factor for nude mice bearing KK-47 bladder cancer.

Authors:  T Amano; K Kumini; K Nakashima; T Uchibayashi; H Hisazumi
Journal:  J Urol       Date:  1990-08       Impact factor: 7.450

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Gold nanoparticles: From nanomedicine to nanosensing.

Authors:  Po C Chen; Sandra C Mwakwari; Adegboyega K Oyelere
Journal:  Nanotechnol Sci Appl       Date:  2008-11-02

2.  Skin Inflammation Modulation via TNF-α, IL-17, and IL-12 Family Inhibitors Therapy and Cancer Control in Patients with Psoriasis.

Authors:  Daniel Octavian Costache; Oana Feroiu; Adelina Ghilencea; Mihaela Georgescu; Ana Căruntu; Constantin Căruntu; Sorin George Țiplica; Mariana Jinga; Raluca Simona Costache
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

Review 3.  Isolated limb infusion as a model to test new agents to treat metastatic melanoma.

Authors:  Michael E Lidsky; Paul J Speicher; Betty Jiang; Masahito Tsutsui; Douglas S Tyler
Journal:  J Surg Oncol       Date:  2013-11-20       Impact factor: 3.454

4.  Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.

Authors:  Y Tsutsumi; S Tsunoda; H Kamada; T Kihira; S Nakagawa; Y Kaneda; T Kanamori; T Mayumi
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

5.  Selective enhancement by tumor necrosis factor-alpha of vascular permeability of new blood vessels induced with agarose hydrogel-entrapped Meth-A fibrosarcoma cells.

Authors:  N Okada; Y Kaneda; H Miyamoto; Y Yamamoto; H Mizuguchi; Y Tsutsumi; S Nakagawa; T Mayumi
Journal:  Jpn J Cancer Res       Date:  1996-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.